Preferred Supramolecular Organization and Dimer Interfaces of Opioid Receptors from Simulated Self-Association
暂无分享,去创建一个
Davide Provasi | Marta Filizola | Jennifer M. Johnston | Mustafa Burak Boz | M. Filizola | J. M. Johnston | D. Provasi | M. Boz | J. Johnston
[1] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[2] Physikalische Gesellschaft. Position-dependent diffusion coefficients and free energies from Bayesian analysis of equilibrium and replica molecular dynamics simulations , 2005 .
[3] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[4] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[5] R. Metzler,et al. Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes. , 2013, Faraday discussions.
[6] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[7] David J. Daniels,et al. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. , 2004, Journal of medicinal chemistry.
[8] Siewert J Marrink,et al. Transmembrane helices can induce domain formation in crowded model membranes. , 2012, Biochimica et biophysica acta.
[9] Bryan L. Roth,et al. Molecular control of δ-opioid receptor signalling , 2014, Nature.
[10] D. Tieleman,et al. The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.
[11] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[12] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.
[13] L. Devi,et al. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity , 2013, Proceedings of the National Academy of Sciences.
[14] Shaoqiu He,et al. Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation , 2011, Neuron.
[15] J. Pintar,et al. Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands , 2010, Psychopharmacology.
[16] Lakshmi A Devi,et al. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Filizola,et al. Lessons from Free Energy Simulations of δ-Opioid Receptor Homodimers Involving the Fourth Transmembrane Helix† , 2010, Biochemistry.
[18] George Khelashvili,et al. Membrane Driven Spatial Organization of GPCRs , 2013, Scientific Reports.
[19] Martin J. Lohse,et al. G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives , 2014, Pharmacological Reviews.
[20] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[21] Xavier Periole,et al. Combining an Elastic Network With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular Recognition. , 2009, Journal of chemical theory and computation.
[22] H. Kramers. Brownian motion in a field of force and the diffusion model of chemical reactions , 1940 .
[23] Jianyun Huang,et al. Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.
[24] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[25] R. Larson,et al. The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.
[26] Siewert J Marrink,et al. Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. , 2012, Journal of the American Chemical Society.
[27] J. Whistler,et al. Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers. , 2012, ACS medicinal chemistry letters.
[28] Marta Filizola,et al. Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors , 2014, PloS one.
[29] Jamie Fong,et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Mantovani,et al. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.
[31] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[32] Dynamical exchanges in facilitated models of supercooled liquids. , 2005, The Journal of chemical physics.
[33] David Baker,et al. Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.
[34] Titiwat Sungkaworn,et al. Single-molecule analysis of fluorescently labeled G-protein–coupled receptors reveals complexes with distinct dynamics and organization , 2012, Proceedings of the National Academy of Sciences.
[35] C. Jarzynski. Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.
[36] J. Klafter,et al. The random walk's guide to anomalous diffusion: a fractional dynamics approach , 2000 .
[37] George Khelashvili,et al. Quantitative modeling of membrane deformations by multihelical membrane proteins: application to G-protein coupled receptors. , 2011, Biophysical journal.
[38] J. Mulder,et al. Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration , 2010, Science Signaling.
[39] H. Loh,et al. Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling , 2012, BMC Cell Biology.
[40] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[41] L. Devi,et al. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10 , 2014, British journal of pharmacology.
[42] Peter M. Kasson,et al. Dynamic heterogeneity controls diffusion and viscosity near biological interfaces , 2014, Nature Communications.
[43] David J. Daniels,et al. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. , 2007, European journal of pharmacology.
[44] Andrew Thomas,et al. The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.
[45] Mark S. P. Sansom,et al. Reduced Lateral Mobility of Lipids and Proteins in Crowded Membranes , 2013, PLoS Comput. Biol..
[46] Marta Filizola,et al. Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery? , 2010, Life sciences.
[47] Lakshmi A. Devi,et al. A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia , 2004 .
[48] Veronika Kralj-Iglič,et al. Interaction between two cylindrical inclusions in a symmetric lipid bilayer , 2003 .